Premium
Using wearable monitors to assess daily walking limitations induced by ischemic pain in peripheral artery disease
Author(s) -
Chaudru Ségolène,
Jehannin Pierre,
de Müllenheim PierreYves,
Klein Hélène,
Jaquinandi Vincent,
Mahé Guillaume,
Le Faucheur Alexis
Publication year - 2019
Publication title -
scandinavian journal of medicine and science in sports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.575
H-Index - 115
eISSN - 1600-0838
pISSN - 0905-7188
DOI - 10.1111/sms.13511
Subject(s) - medicine , treadmill , activity monitor , arterial disease , physical therapy , physical medicine and rehabilitation , physical activity , vascular disease
Purpose To develop, assess the feasibility of, and determine the clinical validity of an event‐based analysis method using wearable monitors to quantify walking pain manifestations (WPMs) and stops induced by walking pain (SIWPs) during daily life walking in people with peripheral artery disease (PAD). Methods The following two conditions were studied: a standardized outdoor walking session (OWS) and a seven‐day free‐living measurement (FLM) period. The PAD participants (n = 23) wore an accelerometer and a watch. They were asked to press the event marker button on the watch to indicate events related to WPMs and SIWPs. To assess the clinical validity of the method, the computed pain‐free walking time (PFWT) and maximal walking time (MWT) were compared with the PFWT and MWT assessed using standard treadmill walking protocols, respectively. Results Following OWSs, the PFWT [OWS] and MWT [OWS] were significantly correlated with the PFWT [Strandness] ( r = .955, P < .001) and MWT [Strandness] ( r = .821, P < .001), respectively. During the FLM, PAD participants experienced only 2 WPMs/day and 1 SIWP/day, although severely limited on the treadmill and during the OWS. The average WPMs/day were moderately correlated with the PFWT [Strandness] ( r = −.54, P = .016). The PFWT [FLM] was on average 12 times longer than the PFWT [Strandness] . Interestingly, the intensity of the walking bouts as assessed by the accelerometer counts during the FLM was significantly lower than that during the OWS (45 ± 15 vs 66 ± 20 counts/s, P < .001). Conclusion This new method offers opportunities for studies investigating the experience of living with PAD and the assessment of daily life walking capacity for both diagnostic and therapeutic purposes.